Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
In the Trixie/JnJ scenario, wasn't the rumor that JnJ was looking to buy Trixie? A buyout is a completely different situation than someone supplying widgets. If it was a large company supplying end effectors and it was announced as part of a combined supplier and distribution deal, that too should move the needle substantially. But just end effectors? Why is that so much more important than the camera supplier, or electronic control circuit boards, or motors and actuators? We need them all, and they will source each part appropriately. I'm just not convinced that knowing who makes end effectors will drive the stock price upward. I WISH it would; we can use all the help we can get right now for PPS drivers! I hope you are ultimately right, and this is just another thing that I don't understand fully.
Message in reply to:
Im surprised that you don't see how it would positively affect the stock. In my opinion if the supplier is a company like JnJ, it would provide credibility to the Titan SPORT platform that in essence would validate it. Also, the supplier would be a potential suitor for acquisition. If Titan were tied to a company like JnJ, just news like that would put more eyes and bring investors. Do you remember when the rumor of JnJ being tied to TRXC drove that stock way up (even though it was false from the get go)? It would be reasonable to expect that if Titan were associated with a supplier like JnJ then it would impact the share price.
I understand why design freeze should drive the price higher; I hope that is true when it happens but this stock does have a propensity to ignore good news or react contrarily.
There has long been speculation that the announcement of end effector supplier would also drive our price up. I never understood the logic there. Someone will supply out end effectors. I'm not sure why the supplier's identity would drive our market cap anywhere. For the supplier, it should be a nice motivator for their shares to climb on - we anticipate reasonable market penetration with our game-changing technology over the next few years; the supplier should see comparable growth based on our utilization of their end effectors - even more spo because once we sell a system, they supply end effectors regularly for the life of that robotic system. The supplier's stock price should rise because each robot represents a future revenue stream.
I am failing to understand why this announcement would drive us higher as well.
Message in reply to:
There is always shorting going on - only thing to really put a wrench in shorters playbook is to have positive developments/news but in an unpredictable pattern.
This stock has gone up quite a bit for 2 straight days on pure speculation (no news just a rumor of one potentially coming) - now based on movement it could be positive news. If something positive comes out this week(can't imagine it will be the WW Global Supplier of End Effectors - one can only hope), maybe followed up with another positive bit of news next week then more uncertainty has been created for shorters. Then it creeps in that Design Freeze could come at any minute so they could be caught with pants down. It is just over a month until AGM - IF NEWS comes out this week, it will be very interesting to see what it is. The good news is that every day closer to design freeze means the value goes up every day. Upon Design Freeze value of Titan goes way up.
Rocko, I understand that, but multiport is old tech and single port is new tech. Think of ISRG as GM and Titan as Tesla... GM will still sell a lot more gas powered vehicles as they transition more toward electric, but Tesla is absolutely not going to start developing a gas powered vehicle.
Message in reply to:
with all due respect, Multi-Port is not going away anytime soon - you have tens of thousands of doctors who do multi-port that will continue to use it. For example, JnJ which will get into robotics will have:
Multi-port
Single-port
Bronch
Still be a player in Laproscopic
You know that the market won't go from Multi-port to Single Port overnight, it would take over a decade - any player in robotics will have to have both Multi and SP
Why would Titan want to backtrack their technology by three decades? Single port is the now-and-future of surgery, only to be followed by natural orifice entry, more arms in one port, and further miniaturization without losing force. Maybe some added technological advancements like better cutting/stitching/stapling methods and more efficient tissue removal processes. If we really want to backtrack, let's go all the way and have the robot cut the patient wide open from the outside and leave those nice six inch scars again!
On a more positive note, it's nice to see we made Benzinga's Top Movers list on the high side for a change! And pre-market has us already up another $0.25 today.
There was once a lot of chatter about Phil from Northland being a bit leaky when it comes to raises... Other than that, I haven't heard anything specific except to note that most press releases are preceded by fairly substantial buying or selling - implying there may be other leaks, and therefore also implying that today's upward price action may be foretelling a nice PR tomorrow. All observation and opinion here, I am not hereby making any claims of verifiable fact.
Message in reply to:
Shorters get a warning before the news hits?
Thank you, SPORT19! I will absolutely revel in the (possibly) temporary victory we are experiencing today, and I appreciate your support.
Message in reply to:
This isn’t about people’s feelings, it’s about investing money. This is being manipulated.
Enjoy your celebration while it lasts.
We've been patiently, frustratingly sitting here day after day watching major chunks of our investment temporarily dissipate from our accounts. Briefly, at least, we have been able to watch a partial restoration of our recent losses. We have ALL seen this before; we have ups and we have downs. Is there some reason that anyone who has been so thorough and methodical in reinforcing the miserable times would now want to turn a celebratory day into another day of misery?
Message in reply to:
Careful here.....
Seem this many times before.
Jay D... You in Canada? I'm seeing a high today of $2.55. At least for now!
This is the perfect example of the conundrum that Titan management is in. They publish a timeline/schedule, like most development stage companies do. If they didn't, folks would complain that they aren't sharing enough information. Since they did share the schedule (as they rightfully should) they are now getting beat upon for... sharing information! Damned if they do and damned if they don't... and the whiners will beat on them no matter what Titan does.
Message in reply to:
Mac should not have been so telling with times. because it leaves open space for manipulation.
The general consensus seemed to be that design freeze will be announced right after AGM, or possibly during. No real substantiation for that though, other than convenient timing and fits the Q2 milestone, but as Quid just pointed out, they have until end of June to still meet the milestone. Since they have been hitting milestones pretty faithfully as of late, it does sound like a reasonable plan to announce as soon as possible. Most likely, there are still numerous documentation requirements to be completed before being able to declare design freeze. If they got a jump in internal documentation, then May should certainly be feasible. I hope this is sufficiently on topic.
Message in reply to:
Mc affirmed they are still on course, which as laid out previously had DF happening in H1 2019. That gives them through the end of June , technically. Now my memory is quite bad so i could be wrong but I believe this is accurate.
Gathered up all my loose change, brought it all to the bank, got a check for my trading account... Picked up a few hundred more shares this morning. Putting my money where my mouth is, so to speak... Wish everyone would do that! Then they'd have nothing left to complain about!
Nice! Better yet, what can CHARDONNAY be an acronym for?
We have haptic feedback. da Vinci does not, yet they own the market. Senhance does have it but the few surgeons who commented on it seemed underwhelmed, saying it didn't feel natural. Titan had haptic feedback for Amadeus and supposedly had done a lot of fine tuning; hopefully their homework back then will pay off with a much more natural-feeling control system for SPORT, or whatever the rebranded device will be called. I don't think it was in the earlier SPORT from last year's trials... anyone know for sure?
With the added features, 2 cameras, better resolution, haptics, etc., I can't wait for feedback to start coming in once surgeons begin the trials with this new design!
Message in reply to:
Further, we have improved the surgeon interface at the workstation with a more comfortable handle design, a new 4K monitor and upgraded haptic feedback with image overlays to assist the surgeon with the positioning of the instruments for optimal performance.
Force feedback and Haptic feedback integrated into the new design. The sense of touch in Robotics has always been lost in Robotic surgery. Lets not forget our solid IP.. ISRG daVinci has ZERO force feedback or haptic feedback integrated in their robots!
If you've had enough, what keeps bring you back here? You must be seeing some positive here or you would follow your own advice and be gone.
Message in reply to:
So this is going to be the next biggest robot competitor with the likes of davincci, Medtronic, Google, and other BIG well known names... the greatest next thing with "snake arms".. 5 yrs ago I questioned why we are so unknown if true and why we were at only at around 2 bucks pps.
Now 5 yrs later after a reverse split taking away 80% value and again only at 2 bucks. Now I really question what is wrong here.. while you all are scooping the officers and CEO don't buy it and now want their options priced lower. Sounds exactly like a company to NOT invest in.. design freeze coming sometime..maybe soon but just 2 bucks... sure it's because they CAN'T invest in stocks under 10$. Something IS seriously wrong here. But keep on scooping.. and I'm just pointing out the slap your face off obvious... there is so much more wrong here. Ya know..fool me once twice..three.. when I got to fool me 6+ times I've had enough. Still hurting for all the people I told about getting into this for the last 10 years. I've been a fool.
Dr. MacD,
I respectfully disagree. And unlike most of the times when someone says "respectfully", I do actually mean it. Your post was well written; you stated your opinions and followed through with substantiation. But I still disagree with some of your points, and hope to provide similar levels of substantiation.
First, a takeover today would require a vote by shareholders. I do not believe a majority of shareholders would accept a buyout offer which doesn't put most warrants in the money. There are tons of them left at $3.40 and the new batch at $4. Do you really think anyone in their right mind would take a $4 buyout offer? Well, not everyone is in their right mind, but I feel certain that a majority would shoot it down.
You claim that Titan is not seen as a threat to any player in that field. If that were true, why would the biggest players be after our top talent? Mr. Brar, Mr. Jensen, Dr. Genova... Titan isn't selling a product yet, so there is no loss from any potential patent infringement as of yet; they can't sue Titan until they can claim loss. Capital has been hard for Titan to come by, possibly due to influence from these competitive robotic megalopolies, but we still manage to scrape up the needed funds to continue. The most harm these competitors could do to our program is to snipe our top talent pool, and that is what they are attempting. They know the eventual threat is real but there is little they can do to stop Titan at this juncture. They are doing what they can by trying to break up the band (and our vote FOR repricing options will help keep this team together to the finish line).
I find your financial estimates reasonable ($50M + $50M). A distribution deal can help mitigate some of the second $50M chunk if they pursue such a deal. Announcements of Design Freeze, FDA filing, FDA and CE approvals, etc. should easily put at least that much cash in their pockets via warrant exercise. I can't rule out the possibility of one more raise before then but I remain hopeful they can get by without it.
I, for one, have never sold a share of my Titan stock, and I have been accumulating more whenever the (financial) opportunity arises. As much as I may be considered somewhat of a "cheerleader" for this stock, I believe I have not yet used either the word "scoop" or "rah" in any of my posts. I try to assess information logically, and occasionally share the results of my assessments out here.
Therefore, as you suggest, I derive my "wishful bliss" from observations, some factual and some borne of interpretation. To these ends, as I shared with a friend of mine just this morning, I was reviewing the most recent Annual Information form on Sedar. I observed that Titan is "awaiting confirmation of schedule for preliminary audit of quality system by European Notified Body." Although the plan is to launch in the Eastern U.S., such early progress with the EU should bode well for the idea that European marketing will commence shortly thereafter, so they are not planning to wait around or progress TOO slowly, merely cautiously when entering the market.
I then observed (Q2, Milestone 5) "verify production system operation..." I interpret this to mean that the current system is believed to be the production system, as we are already in Q2. The statement is intended to convey the "verification" aspect of the sentence, but it inherently states that the hardware they are working with is, for all intents and purposes, the Production System - and I say this with better than 90% confidence. I'm not 100% sure of this interpretation due to the ambiguity in the first Milestone 5 statement (Update system design and related hardware and software documentation). It would not make sense for it to mean they are updating the design of the instrument at this juncture, but an argument could be made that they are combining design and documentation tasks into this one entry; my belief is that this entry is entirely a documentation task which could have been more clearly expressed as "Update system design documentation and related hardware documentation and software documentation." Also, if said task was more than just documentation, it is highly unlikely that any design changes could be documented, built, module tested, integrated, and system tested all within the bounds of Q2. Design Freeze has not been declared, but I find their wording to be as close as possible to declaring it. To further substantiate this, the list of Milestone 5 achievements places Design Freeze in the middle, not at the end. It is not unreasonable to presume some reasonable sequence in the list (e.g. updating the documentation must precede some of the other entries). Design freeze could therefore be substantially earlier than the end of June, given the tasks they list after that entry.
As for the broader bear market conditions for medtechs, I will note that ISRG's high for today is within a dollar of its all time high; one could hypothesize that the surgical robotic market isn't entirely beholden to the trading patterns of other medtech companies.
All my opinion and interpretation, submitted for your consideration, with respect.
Message in reply to:
I believe most warrants would be out of the money if there was a takeover today. No one knows why J&J overpaid for their acquisition into this field but we do know they were very well connected and had loads of cash to progress their development.
Investors will do what is best for their bottom line. Warrants will be worth little upon a takeover since then the time value would be missing and you would be FAR better off to buy the common shares. Your assumption of a huge premium implies someone is desperate for Titan technology whereas the market has not indicated that to the be case at all. That is not to say that someone should not be interested but the reality is Titan is not seen as a threat at the moment to any player in that field.
I have stated before that Titan needs $50M per year until FDA approval and then $50M minimum to roll out the product line commercially since there will be no profits for the first year as orders will be small while potential buyers test it on a small scale.
Scoop ... scoop ... rah ... rah ... rah. I do not believe for a second that these posters are constantly buying and never selling their shares. That is ridiculous and particularly when all they can say is silly phrases like scoop and provide wishful bliss.
Still watching but not buying at the moment. I believe cash will be harde to come by and the spend will be relentless due to broader bear market conditions for medtechs that are outside of Titan control unfortunately.
If I had the funds today, I would be buying.
The last time I had the opportunity, I bought more. My goal is to continue to own at least 0.15% of the company. Before this dilution, I was up over 0.2% as a hedge against the imminent dilution (which just happened) so now I'm back to about 0.157% (48K shares).
Realistically, they could announce design freeze almost any time. We're figuring probably in the June time frame, but I'm not willing to risk missing the boat when it finally sails. I just need to get more funding together to keep pace with the next round of dilution, if it happens, plus upcoming dilution from eventual exercise of warrants.
Keep in mind, a week ago we had 22M shares OS at just under $3/share, or a market cap of right around $60M. Right now, we are showing 30.6M OS with a market cap of over $80M. From a Market Cap perspective, we are up 33% from a week ago.
Sorry if the FACTS accidentally indicate positive news... I know that isn't popular here.
SPORT,
If you listened to the conference call, you may have noted that his plea for reduced options strike price was not for his options. He is concerned about potentially losing other CRITICAL personnel (Mr. Genova, Mr. Jensen, Mr. Brar) to competitors. They would LOVE to get their hands on any and all three. Mr. Brar is probably more familiar with ISRG's patent portfolio than anyone at ISRG!
If I can help retain these talented and CRUCIAL individuals, I will do so. I am voting YES for the repricing in order to protect the viability of my investment by preserving this team.
I respectfully request that you research this issue further and reconsider your vote.
Thank you,
Mustang
P.S. If the rebranding comes to fruition, will you be following suit with your login name? Just curious...
Message in reply to:
After doing a 1-30 RS and driving PPS to all time lows MacNally has the balls to whine about his options being too far out of the money to be an incentive to work at Titan! On a conference call no less....
UNREAL
VOTE NO!
2014/2015 was a different management team, and a crude instrument not even close to ready for market. They were not the right team to bring it to market (but did a great job with the concept!).
These guys here now know how to bring a product to the market - including naming (with FDA help).
urosurg, I believe that was part of the plan... the gel port was to allow access for a trocar or other additional manual instrument alongside the main insertion tube.
It would be interesting to dig to see if the available information still describes a 25mm incision or if it requires a larger incision, with the insertion tube being a 25mm OD.
Message in reply to:
Generally speaking, one can't do traditional lap surgery through a gel port. The lap instruments have to be far enough apart (generally a handbreadth or more) to triangulate tissues. For Titan, a gel port could allow the assistant at the bedside to access the abdomen through the gel port erasing the need for an additional assistant port. The DaVinci SP (single port) for example, requires a second incision for an bedside assistant port to be placed for suction, tissue manipulation, etc. For the majority of operations that require bedside assistance, the DaVinci SP is not truly single port. It is single port plus 1 or 2 ports. The gel port for the titan could allow truly single incision surgery. Just my 2 cents...
I'm looking forward to seeing da Vinci customers buying a SPORT, and six months later buying one or two more because the surgeons and staff prefer it so much over da Vinci!
Message in reply to:
If Columbia is an early adopter that would set the table well
Day off, just catching up... But I did sell my Targa Resources (3 years in, sold for 60+% profit plus 3 years of 8 to 14% dividends so doubled in 3 years) and used the proceeds for TMDI. 13,200 more shares today, and stoked about it! Bring on the Bloom Burton Boom!
I still have a sell order on all my non-IRA shares with a $200 price. Shares in an IRA cannot be lent out (according to my Wells Fargo advisor) and shares that are for sale also cannot be borrowed. And if someone wanted to pay $200 for them right now, I'd be very happy!
Message in reply to:
My broker just called looking for TMDI shares to lend to short sellers claiming it is very hard to borrow now. Anyone else getting those calls?
Quid, my understanding from a few years ago was that Medtronic's robot "Hugo" was multiport, but I had heard rumblings about their robot Einstein as well. I never knew if it was the same robot or if they are working on multiple platforms at once; I would think they would want to get something to market, especially after last year's schedule slip.
Just ran into this:
https://www.medtechy.com/articles/2019/medtronic-ceo-provides-update-on-robotic-surgery-program
In 2016, they (MDT) said they planned to roll it out in India first and hoped to be generating revenue with it in the US by end of 2019. With the slip of about a year that they announced last February(-ish) that pushes them out to 2020, and this article seems to question if they will hit that target. The upshot is that it would appear Medtronic won't have any sort of market foothold when Titan launches, and Mr. McNally recently said they now want to roll out on the East Coast (US) first.
I am more concerned about Medrobotics; their current focus appears to be "trans-orifice" at the moment but I assume it could adapt easily to an abdominal port.
And with JnJ, one never knows what they are hiding! But if the combined IP of ISRG and Mr. Brar's program can hold off single-port competition, it will be a huge score for us.
Quid, I'm curious about the type of position of these folks you talked to... Clinical, Engineering, Finance, Marketing types?
It is presumed (and reasonable to believe) that JnJ and Medtronic will be entering the general/abdominal robotic surgery market in the foreseeable future. Intuitive is pushing their SP system as being beneficial for patient outcomes. Surgeons who have tried the SPORT system have been very clear with their opinions on ease of use. My question is this: Why would new entrants to the market not want to employ the state of the art technologies to optimize the patient care experience?
At this point, I can only hypothesize that maybe ISRG and Titan have single port tech wrapped up too tightly with their IP portfolios, and additional entrants in the market will need to rely on old tech, like some of ISRG's earlier patents which have expired. If that was true, Titan should truly have an absolutely golden pathway being paved ahead of us for the next 10 to 15 years!
In your conversations with these folks, both said "no single port" but did either say why? Are you still in contact with these people, and able to toss out that question? The answer could really improve Titan's outlook as an investment, which would benefit all of us greatly!
Or to use common iHub vernacular... It would be HUUGEEEEEE!
Also... Thank you for sharing! It's nice to have folks like you and BigT (and several others, of course!) who maintain a pleasant demeanor and add rational content to the board.
Message in reply to:
I recently spoke with mid levem leadership at JNJ, for what it's worth they anticipate having a robot competing with the daVinci platform in ~2 years. They stated no single port. Medtronic said the same in a recent conversation. However JNJ said their strategy is both to buy and make their own robots. I also learned VERB has access to utilize all Google's patents.
Waiting for that last trading hour pop! Ought to be able to close at or above $3 today. If we don't, it's my fault for jinxing it by mentioning it. But we should!
My "nice scoop" was 4800 shares yesterday at $3.00. I'm happy with that. Had to sell something else, but I have my priorities!
Message in reply to:
That’s the spirit sport!
$2.80 was a nice scoop today folks!
Let’s close above $3 and never look back!
Giddy up!
Well, congratulations! And welcome to the not-so-Dark Side! I guess Shorty McShortface won't work (and soon, none us longs will have any reason for a long face either!).
I think you found a great time to buy in big. If you went from no holdings to a large position today, your cost average is half of mine, so... Nice score!
Message in reply to:
Well Folks - since I love 85% of 80% of you, it is at this time that I would like to announce that I am LONG Titan Medical, with no plans to sell a single share until this hits $100. Yes, that is correct - I am fully committed to see it through until buyout and beyond !
I would be crazy not to be invested heavily at this time as the March Presentation confirms that they are "on track". Come Monday afternoon (3/18), institutions will start to lick their lips and I fully expect that this will be their last raise. The combination of it closing soon and this conference, will result in a hefty PPS increase.
After design freeze hits in June, it's game on ! I would be a complete fool not to be in this when the fireworks are lit. Speaking of "lit" that is what I am going to do the rest of the afternoon - get lit in celebration of my LARGE purchase of TMDI ! GLTA
HC, what you should do is allow the iHub community to choose your StockTwits ID. We can create a list of five names and then everyone votes on their favorite. And like with the similar crowd-naming exercise for that Antarctic research vessel from England, you can ignore the results (Boaty McBoatface) and pick your own name anyway.
I know you have this board split on opinions as to whether or not you're really a long in disguise or really a shorter who wants to play nice on occasion, but I wouldn't be surprised if, based on the failed British naming experiment, the top three could include Shorty McShortface. Then you would be free to call yourself SS David Attenborough (like the Brits did) or just stick with Honeycomb. Maybe pick a new number at the end. That should confuse a few people!
I think if I were to join StockTwits I would just use the same ID as here, otherwise I would probably just confuse myself! Hell, I don't even own a Mustang at the moment!
Do you need a Twitter account to post to StockTwits? Just curious...
Message in reply to:
Am I allowed to join ? Midgetsticks could be my moniker
I thought I had read somewhere that the regulatory strategy Titan was using would not rely on the predicate device, in case there are issues or concerns with how the two systems correlate for performance. It sounded as though they were preparing for full blown PMA scenario but still hoping to use the predicate device for 510K could shortcut that. One more way that they could come in ahead of schedule, I suppose!
Message in reply to:
At the end of the day, it all boils down to the fact that a major medical device player will NEED a robotic platform to compete with ISRG in the robotic Surgical space. We are seeing surgical robotic acquisitions go for 1B+ (Mazor for 1.7B, Auris 3.4B). Titan has a market cap right now of 75M, the opportunity is to make 10, 20, 30X current trading levels. The rest is noise, and should only concern you when you are trying to trade/short this stock. As someone who is in this space, someone who is seeing strategic robotic programs being set up by surgeons to drive patient volumes, TRUST me that a MAJOR medical device player would love to add SPORT to an existing surgical sales team and portfolio and go to market, compete and win business away from ISRG. MDT and JNJ are first to mind, but there are other med device players that would love to add SPORT and go to market. Once the technology is 510k approved it’s on, and remember ISRG got SP FDA approved, which means Titan only has to prove they have a predicate device, hence the 510k process vs full blown FDA approval. The heavy lifting is done, 510k is much easier, faster, and less costly.
Tootall, Design freeze in Q2, yes... Just an observation, but that is less than 3 weeks away! This thing could catch fire a lot sooner than most people seem to anticipate.
Message in reply to:
What am I missing? Unlike 2 months ago, the company now is fully cashed up through FDA approval. And unlike even 3 months ago, the company appears on time for the Design Freeze. A group of informed surgeons perhaps two years ago bought in at a higher price than the current price, when the company was far less capable. Apart from the numerous accolades from independent experts in Europe and elsewhere, this group of surgeons must be given some respect for knowning what they are talking about. Money talks.
the current market cap must be in related in part simply through lack of market knowledge. Perhaps as many here have suggested, the fun begins with Design Freeze. Then marketing is appropriate, and any trials should be relatively brief. Design Freeze was moved up to Q2, and submission this year, per management. I like the odds of a steady stock rise. The Ducks are in order. Market cap (w/ or w/o warrents) is very cheap.
I think once there is a design freeze, which is just several months away, the company will have something exciting to crow about to the investment community. Single Port.
Nice!
Last time, it about doubled, then held half that gain (roughly) for 5 months. A repeat performance would have us spike to $9 or $10, then hover around $6 to $7 until August, at which point the formal Design Freeze announcement should have us shooting up MUCH further! Sounds like the makings of a really really (really) good year!
I think you forgot the rest of the "E"s in your "Huge!!"
Message in reply to:
Huge!!
https://stocktwits.com/CNMi670/message/155787561
posilock, post 82702. He seems to have a good connection to Mr. Randall on occasion so there may be some reason for his optimism regarding the conference outcome.
Message in reply to:
Rumors from what source? Here?
posilock Thursday, 02/28/19 04:18:54 PM
Re: RockoTaco post# 82701 0
Post # of 82736
Things getting exciting in here heard the two days of investor conference went very well....
So pre-market someone bought a whopping 25 shares at $4. At open, someone else bought 9 shares at $3.95. A little price manipulation going on here?
We need a real RUN!
Not sure what the Golden Cross means (I'm in tech, not investment/finance) but it sounds promising! Two more patents issued yesterday and rumors that the conference went very well, so maybe this is the beginning of the breakout we've all been waiting for!
Message in reply to:
Pre market trades at 4.
Last time this was a sign of a string move up if you recall.
Golden cross forming!
Trixie getting hammered again today. I don't feel so bad about being down two cents at the moment.
But he only sold two thirds of his holdings... and he also picked more up at a big discount!
Message in reply to:
Interesting info on TRXC - seems trixie's CFO sold more shares on Feb 22. WOW!
https://www.fairfieldcurrent.com/news/2019/02/27/transenterix-trxc-stock-price-down-14-7-after-earnings-miss.html
DHug, I was really thinking predominantly in terms of shares held vs. outstanding shares. TD Ameritrade shows us having around 22M shares outstanding. My 31K shares represents about 0.0014 (or 0.14%) of all outstanding shares. I might be a fairly average shareholder among the typical iHub poster here. The top 15 to 20 posters here combined probably hold (ballpark numbers, obviously) somewhere between 1.5% to 3% of all outstanding shares.
The typical iHub poster on this board seems to be a retail investor, maybe like me, trying to score a home run for an early retirement or some other relatively short-term (a few years maybe?) financial goal, or maybe some day traders, and of course the shorters with their agenda are sprinkled in, but their churn doesn't represent a steady percentage of shares held, so they don't really count for my assessment. Institutional investors don't seem to contribute posts here, and for all I know they might not be allowed to for legal reasons.
My intended point was that us 0.1 percenters aren't really going to move the needle much as individuals, especially compared to institutions holding several percent of outstanding shares. Even before I clicked Submit on that original post, I hoped "small potatoes" and "aren't that big a deal" wouldn't be interpreted as an insult, but I still feel it is a mathematical reality for this situation.
To your actual question... as to the extent "new investors" and "old investors" matter, old investors tend to be us longs, in for the long haul. If we all bailed at once, there would be a hit to the PPS but we've had days recently where nearly 5% of outstanding shares were traded, so that hit would be absorbed quickly. New investors, like us old, may be mathematically "small potatoes", just beginning the accrual process of Titan shares whereas old investors have been accumulating shares for years. However, the new investors are more important than the math suggests, because it means word is getting out, and some folks have the wherewithal to catch this train before it leaves the station. That word getting out can also catch the eye of a larger investor, institutional or otherwise (remember the surgeon-led private placement!) which can become mathematically significant very quickly!
Message in reply to:
You said in your post "And new investors who post here aren't that big a deal in reality (small potatoes in the grand scheme of things)" ... Another perspective is that w/o the "new" investors the "old" investors could have been S.O.L. had it not been for the additional $$ invested to keep Titan going ... If you would be so kind, please expound on the difference(s)
between "old" and "new" investors as you understand them ... ALWAYS several ways to look at life friend.
I'd hardly call that fair. The current management team took over a stalled project and attempted to pick up those pieces, including some schedule projections, when they first came on board. As they starting diving deeper into the project, they realized there was more work to be done than the old team had originally planned on, so they took one hit to the schedule by putting out a realistic schedule (the first one they planned from the ground up) which would encompass all the work needed to get a game-changing system to the market with latest technologies, so it wouldn't be out-dated when first released.
Showing a timeline from YEARS before they took the reins is not at all applicable, and certainly an unfair representation of today's reality.
Didn't make me laugh at all.
Message in reply to:
Here’s a timeline from 2014 in this MDA..take a look...makes you laugh...
Every management team with this company has blown the timeline and the projected costs BIG TIME!
Almost. iHub, yes, but the Titan board, I beat him by a month to first post.
I know, splitting hairs...
Message in reply to:
Or was here before you
I thought OR Nurse just came on board recently with proceeds from the sale of his house...
And new investors who post here aren't that big a deal in reality (small potatoes in the grand scheme of things), but even institutional investors kicking the tires will discover this spare tire hidden in the truck, and it would be nice if it had more air in it than a Tom Brady football!
Message in reply to:
There hasn’t been a new investor here I years.
I blame McNally he’s over 2 years in and the share price is down from .55 to .12 pre reverse spit.
So smd